Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Colecalciferol EQL Pharma Approval

The pharmaceutical Colecalciferol EQL Pharma tablets 800IU and 2000IU has been approved by the Irish Medicines Agency (HPRA) for sale. Approvals are also expected soon from the Netherlands, Norway and Sweden.Colecalciferol EQL Pharma is a prescription drug that contains Vitamin D3, which helps with the uptake and storage of calcium in the skeleton. It is often given as a preventive treatment for osteoporosis. Colecalciferol EQL Pharma will be launched in Sweden during the company's fourth financial quarter. In Sweden, the market today is valued at SEK 69m with two active competitors. For

Notice to attend the Annual General Meeting of Sivers Semiconductors AB (publ)

The shareholders in Sivers Semiconductors AB (publ) (the “Company”), reg. no. 556383-9348, are hereby invited to attend the Annual General Meeting to be held on Thursday 20 May 2021, only by postal vote.Due to the coronavirus and in an effort to reduce the spread, the Board of Directors has resolved that the Annual General Meeting will be held without the physical presence of shareholders, representatives and third parties, and that the shareholders will only be able to exercise their voting rights through postal voting in accordance with the instructions specified below. Information

High level of activity and stable earnings

· Income for the period January–March 2021 totalled MSEK 1,502 (1,476). · Income from property management amounted to MSEK 779 (794), equivalent to SEK 2.82 (2.91) per share – a change of –3%. · Change in value on properties amounted to MSEK 1,607 (3) and on derivatives to MSEK 19 (–167). · Net income for the period amounted to MSEK 3,840 (482), corresponding to SEK 13.90 (1.76) per share. · Long-term net reinstatement value (EPRA NRV) amounted to SEK 220 per share (193), an increase of 14%. · Net investments amounted to MSEK –9,014 (643) of which MSEK 177 (75) pertained to

AQ Group AB (publ), interim report January - March, 2021

First quarter, January - March 2021 in brief · Organic growth and continued good cost control resulted in a sharp increase in operating profit in the quarter · Net sales decreased by 2.6% to SEK 1,307 million (1,342) · Operating profit (EBIT) increased by 23.7% to SEK 121 million (98) · Profit after financial items (EBT) increased by 45.0% to SEK 126 million (87) · Profit margin before tax (EBT %) was 9.6% (6.5) · Cash flow from operating activities increased to SEK 160 million (141) · Earnings per share after tax amounted to SEK 5.89 (4.11) · Equity ratio was 56% (

World’s Longest Indoor Autonomous Vehicle Test Track Now Open

The automotive industry is undergoing change and tests and trials are being conducted more agilely. AstaZero is now opening the world’s longest indoor track for testing active safety systems and autonomous technologies for all types of vehicles. Vehicle operators are able to conduct tests 24 hours a day, 365 days a year with reproducible light and surfaces.AstaZero is the world’s first full-scale independent testing and demonstration facility for future road safety, and it is now being expanded to house the world’s longest indoor track: 700 metres long and 40 metres wide. AstaZero Dry Zone

Kemira appoints Terhi Kivinen as Chief Communications Officer

Kemira OyjPress releaseApril 21, 2021 at 9.00 am (EEST)Kemira appoints Terhi Kivinen as Chief Communications Officer  Kemira has appointed Terhi Kivinen as Chief Communications Officer of Kemira Oyj starting from May 1, 2021. Terhi Kivinen joined Kemira as Director Global Communications and Stakeholder Relations in March 2020 and prior to Kemira has had a long career in communications, IR, sustainability and marketing in international and Finnish organizations. She will report to Jari Rosendal, President & CEO of Kemira Oyj in her new role.

Nexam Chemical Holding AB (publ) Interim Report 1 January – 31 March 2021

Growth by 26% and best quarter to dateFirst quarter at a glance Significant events: · Continued high growth, +26% compared to the corresponding quarter in 2020. · Both Performance Chemical, + 38%, and Performance Masterbatch, + 15%, are growing compared to the corresponding quarter in 2020. · First commercial order to India amounted to SEK 1,500,000 shipped during the quarter. · Directed new share issue oversubscribed, added SEK 33,534,000 after deduction of transaction costs. · Reactive Recycling, a new offering in recycling, was launched during the quarter.

Solid first quarter – we believe in the future of the office

· Rental income increased to SEK 293 million (285) · Income from property management decreased to SEK 167 million (183) · Profit for the period amounted to SEK 365 million (429) · Property portfolio increased to SEK 22,969 million (22,575) · Earnings per share totalled SEK 3.03 (3.56) · Green financing increased to 61% · Charlotte Hybinette new Chairman of the Board of Platzer · Detailed development plan for Gamlestadens Fabriker becomes legally binding Platzer’s CEO, P-G Persson, said: - Despite the continued problems in society as a consequence of the pandemic,

Interim Report for the period January – March 2021

New data continues to strengthen lecanemabEvents during the first quarter 2021 · BioArctic presented findings at the AD/PD conference suggesting that lecanemab could be developed into a disease modifying treatment for individuals with Down’s syndrome with dementia. · New preliminary results presented from the ongoing open-label extension of the Phase 2b study in early Alzheimer’s disease continued to support the effect of the drug candidate lecanemab on brain amyloid levels. Events after the period · Lecanemab Phase 2b study results in early Alzheimer’s disease published in

Invitation to Eltel’s Q1 2021 report presentation

Eltel will publish its interim report for the first quarter 2021 on Wednesday 28 April 2021 at approximately 08:00 am CEST. On the same day, we are inviting investors, analysts and media to a webcast starting at 11:00 am CEST.The report for the first quarter 2021 will be presented live by Eltel’s CEO Casimir Lindholm and CFO Saila Miettinen-Lähde. The presentation will be held in English. Link to webcast: www.eltelgroup.com. During the presentation, there will be an opportunity to ask questions via the webcast. The presentation material as well as a recording of the webcast will be

Next Phase of ERAS® – Opportunities & Challenges

To date, ERAS has achieved significant benefit for patients and health systems; however, improvements are still needed, particularly in the areas of patient optimization and systematic implementation. During this time of global crisis, the ERAS method of delivering care is required to take surgery and anesthesia to the next level and bring improvements in outcomes to both patients and health systems. For more details, please read here Next Phase ERAS  Encare offers the ERAS® Interactive Audit System 

Transactions in connection with share buy-back programme

On 4 March 2021, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). On 18 March 2021, the share buy-back programme was increased by DKK 15 million, thereby increasing the maximum aggregate purchase price of the shares to be bought back under the programme to DKK 115 million. The share buy-back

Klaria Receives Third Payment from the EU Horizon 2020 Program Supporting the Development of the Sumatriptan Alginate Film

Klaria reports that it has successfully performed and reported the planned activities under the ongoing European Commission Horizon 2020 Innovation Grant (Grant Number 8296159).  The third payment, totaling ca. 2 million SEK has now been confirmed by the EU.  Klaria has thus far received approximately 18,5 million SEK of the total 21 million SEK specified in the grant agreement.  The project will end on June 30[th] of this year and Klaria anticipates receiving the full remaining balance upon successful completion of the final report to the EU.The Horizon 2020 program supporting the

The world’s first demand-controlled ventilation system as a service for commercial kitchens

Technology leader in demanding ventilation, Halton Group, will begin providing their demand-controlled ventilation system, the Halton M.A.R.V.E.L, to commercial kitchens as a service which makes its benefits more conveniently available to more food service operators, such as restaurants, by minimizing the capital cost of the system.The Halton M.A.R.V.E.L system, connected via IoT, helps ensure continuous operation and predictable expenses in professional kitchens through predictive maintenance, and can significantly cut their energy costs and carbon footprint. Commercial kitchens use around

Volati appoints Martin Aronsson as new CFO

Volati has appointed Martin Aronsson as the new Chief Financial Officer for Volati starting October 2021 at the latest. Martin succeeds the current CFO Andreas Stenbäck, who will take over as CEO and President of Volati on May 1[st], 2021. Martin Aronsson comes most recently from the role as Chief Strategy and M&A Officer at Sweco, where he was a member of Group Management. Martin has been responsible for leading Sweco's strategic work, acquisitions, digitization, several cross-group improvement projects and quality assurance. Prior to Sweco, Martin worked at McKinsey & Company as an

Skanska builds Signia by Hilton hotel in Atlanta, USA, for USD 271M, about SEK 2.3 billion

Skanska has signed a contract with Georgia World Congress Center Authority to build the first new construction Signia by Hilton hotel in Atlanta, Georgia, USA. The total contract value is USD 308M for the Skanska-led joint venture along with SG Contracting, Inc. Skanska will include its 88 percent share worth USD 271M, about SEK 2.3 billion, in the US order bookings for the second quarter of 2021.Signia by Hilton is a new upscale brand from Hilton Worldwide Holdings Inc. (NYSE: HLT). The 40-story, 114,000-square-meter hotel will be built to achieve LEED Gold certification and feature 975

Elisa’s Interim Report Q1 2021

ELISA CORPORATION INTERIM REPORT RELEASE 21 APRIL 2021 AT 8:30 AMFirst quarter 2021 financial highlights · Revenue increased by EUR 13m to EUR 482m, mainly due to the camLine acquisition, Elisa Viihde Viaplay cooperation and growth in equipment sales. · Mobile service revenue increased by 0.9 per cent to EUR 210m. · EBITDA grew by EUR 4m to EUR 170m. · EBIT increased by EUR 3m to EUR 102m. · Comparable cash flow decreased by EUR 13m to EUR 60m, mainly due to negative NWC change. · Mobile post-paid ARPU was at the previous quarter’s level, EUR 19.5 (19.3). · Mobile

Interim report January – March 2021

JANUARY – MARCH 2021 · Income amounted to MSEK 571 (430), up 33 percent. · Profit from property management amounted to MSEK 421 (344), up 22 percent. · Profit from property management excluding changes in value and tax in joint ventures amounted to MSEK 283 (260), up 9 percent. · Distributable cash flow per share amounted to SEK 1.15 (1.20), down 4 percent. · Profit after tax amounted to MSEK 639 (659). · Profit after tax per share was SEK 3.46 (3.80). SIGNIFICANT EVENTS DURING AND AFTER THE QUARTER · In February, a retail property was divested for MSEK 220. ·

Nanoform and Aprecia collaborate to advance 3D printed Nanomedicines

Press release Nanoform Finland Plc April 21[st], 2021 08:10 a.m. Finnish time / 07:10 a.m. Swedish time   Nanoform and Aprecia collaborate to advance 3D printed Nanomedicines Helsinki, Finland – Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Aprecia, the 3DP (three-dimensional printing) pharmaceutical company, announce that they are exploring the synergies between their respective technologies in the field of nanoparticle-enabled 3DP dosage forms. This collaboration seeks to provide customers and the pharmaceutical industry with new

Alma Media’s Interim Report January–March 2021: Adjusted operating profit in Q1 was on a par with the comparison period. Significant transactions executed successfully.

Alma media corporation   Interim Report    21 april 2021 at 8.00 A.M. ALMA MEDIA’S INTERIM REPORT JANUARY–MARCH 2021: ADJUSTED OPERATING PROFIT IN Q1 WAS ON A PAR WITH THE COMPARISON PERIOD. SIGNIFICANT TRANSACTIONS EXECUTED SUCCESSFULLY. Alma Media’s new segment structure entered into effect on 1 March 2021. Alma Media also changed its revenue reporting by distributing revenue between marketplaces, media and service revenue. As part of the transition to a new segment structure, the Alma Mediapartners services that were previously reported as part of the Alma Markets business segment

Handelsbanken’s Interim Report January – March 2021

January – March 2021- compared with January – March 2020 · Operating profit increased by 9% to SEK 5,612m (5,142). Adjusted for foreign exchange effects and the year’s provision for Oktogonen, operating profit increased by 15%. · Return on equity inreased to 10.6% (10.3). · Earnings per share increased to SEK 2.21 (1.99). · The common equity tier 1 ratio increased to 20.2% (17.6). · The credit loss ratio was 0.01% (0.08). · Income increased by 1% to SEK 11,292m (11,178). Adjusted for foreign exchange effects, income increased by 3%. · Continued large inflows to the

Ericsson reports first quarter results 2021

First quarter highlights · Sales adjusted for comparable units and currency grew by 10% YoY despite SEK -1.6 b. lower IPR licensing revenues YoY and four of the five market areas showed double-digit growth. Reported sales were SEK 49.8 (49.8) b. · Gross margin excluding restructuring charges improved to 42.9% (40.4%) with margin improvements in all segments despite lower IPR licensing revenues. Reported gross margin improved to 42.8% (39.8%). · EBIT excluding restructuring charges improved to SEK 5.3 b. (10.7%) from SEK 4.6 b. (9.3%) YoY driven by Networks, more than offsetting

SEB joins Net-Zero Banking Alliance to accelerate transition

SEB is together with 42 other banks from across the world forming the Net-Zero Banking Alliance (NZBA) to accelerate the transition of the global economy to net zero emissions by 2050 at the latest. The initiative, which brings together banks with combined assets of $28.5 trillion, means that SEB commits to align operational and attributable emissions from its lending and investment portfolios with pathways to net-zero by 2050 or sooner.The Net-Zero Banking Alliance is part of The Glasgow Financial Alliance for Net Zero (GFANZ) - a global alliance that brings together existing and new net

Notice to Annual General Meeting in Bluefish Pharmaceuticals AB (publ) - Swedish

Aktieägarna i Bluefish Pharmaceuticals AB (publ), org. nr. 556673–9164, (”Bolaget”) kallas härmed till årsstämma onsdagen den 19 maj 2021 Till följd av Covid-19 pandemin har styrelsen beslutat att årsstämman skall genomföras utan fysisk närvaro av aktieägare, ombud och utomstående och att utövande av rösträtt endast kan ske genom poströstning före årsstämman. REGISTRERING OCH ANMÄLAN För att ha rätt att deltaga genom poströstning i årsstämman ska aktieägare dels vara införd i den av Euroclear Sweden AB förda aktieboken tisdagen den 11 maj 2021, dels anmäla sitt deltagande genom att

There are no items matching the current filter
There are no more items matching the current filter
Back to top